SCHEMBL25462147

SCHEMBL25462147

Cc1ccc(S(=O)(=O)NC(=O)COc2ccc3ccc(C)cc3c2)c(C)c1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF3 O95398 6/20 0.89
KMT2A Q03164 4/20 0.52
POLB P06746 4/20 0.52
MEN1 O00255 3/20 0.52
ALDH1A1 P00352 1/20 0.52
MAPT P10636 1/20 0.52
BLM P54132 1/20 0.52
MEP1B Q16820 1/20 0.50
RAB9A P51151 1/20 0.45
PPARG P37231 1/20 0.44
HTT P42858 1/20 0.44
NCOA2 Q15596 1/20 0.44
NCOA1 Q15788 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
NR2E3 Q9Y5X4 1/20 0.44
NCOR2 Q9Y618 1/20 0.44
NCOA3 Q9Y6Q9 1/20 0.44
PTPRC P08575 1/20 0.44
PTPN11 Q06124 1/20 0.44
PTPN13 Q12923 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25462131 0.98 RAPGEF3 (0.89) RAPGEF3KMT2APOLBMEN1ALDH1A1
SCHEMBL25186261 0.92 RAPGEF3 (0.80) RAPGEF3KMT2APOLBMEN1ALDH1A1
SCHEMBL25463585 0.92 RAPGEF3 (0.77) RAPGEF3KMT2APOLBMEN1ALDH1A1
SCHEMBL30439576 0.90 RAPGEF3 (0.80) RAPGEF3KMT2APOLBMEN1ALDH1A1
SCHEMBL23843612 0.90 RAPGEF3 (0.80) RAPGEF3KMT2APOLBMEN1ALDH1A1
SCHEMBL25182638 0.90 RAPGEF3 (0.80) RAPGEF3KMT2APOLBMEN1ALDH1A1
SCHEMBL25463592 0.86 RAPGEF3 (0.68) RAPGEF3KMT2APOLBMEN1ALDH1A1
SCHEMBL25179969 0.85 RAPGEF3 (0.72) RAPGEF3KMT2APOLBMEN1ALDH1A1
SCHEMBL25462255 0.84 RAPGEF3 (0.81) RAPGEF3KMT2APOLBMEN1ALDH1A1
SCHEMBL25463008 0.83 RAPGEF3 (0.70) RAPGEF3KMT2APOLBMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150929-A1 SELECTIVE NON-CYCLIC NUCLEOTIDE ACTIVATORS FOR THE CAMP SENSOR EPAC1 UNIV TEXAS (US) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150929-A1 SELECTIVE NON-CYCLIC NUCLEOTIDE ACTIVATORS FOR THE CAMP SENSOR EPAC1 CREB1, RAPGEF4, ATF4 RAPGEF3 4/4885KMT2A 4380/4885POLB 3854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.